These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 30915507

  • 1. Hypophosphatasia: Canadian update on diagnosis and management.
    Khan AA, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg CR.
    Osteoporos Int; 2019 Sep; 30(9):1713-1722. PubMed ID: 30915507
    [Abstract] [Full Text] [Related]

  • 2. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 3. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H, Yasuda S, Kakoi S, Ohata Y, Shimizu Y, Hasegawa C, Hayakawa A, Akiyama T, Yagi T, Aotani D, Imaeda K, Ozono K, Kataoka H, Tanaka T.
    Intern Med; 2020 Mar 15; 59(6):811-815. PubMed ID: 31787692
    [Abstract] [Full Text] [Related]

  • 4. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr 15; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 5. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 15; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 6. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA, Foster BL.
    Drug Des Devel Ther; 2018 Jun 16; 12():3147-3161. PubMed ID: 30288020
    [Abstract] [Full Text] [Related]

  • 9. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 16; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 10. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May 16; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 11. Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Del Angel G, Zhou S, Rush ET.
    Mol Genet Metab; 2021 May 16; 133(1):113-121. PubMed ID: 33814268
    [Abstract] [Full Text] [Related]

  • 12. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 16; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 13. Enzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasia.
    Liu J, Campbell C, Nam HK, Caron A, Yadav MC, Millán JL, Hatch NE.
    Bone; 2015 Sep 16; 78():203-11. PubMed ID: 25959417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypophosphatasia: A Unique Disorder of Bone Mineralization.
    Villa-Suárez JM, García-Fontana C, Andújar-Vera F, González-Salvatierra S, de Haro-Muñoz T, Contreras-Bolívar V, García-Fontana B, Muñoz-Torres M.
    Int J Mol Sci; 2021 Apr 21; 22(9):. PubMed ID: 33919113
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of asfotase alfa in patients with hypophosphatasia: A systematic review.
    Shirinezhad A, Esmaeili S, Azarboo A, Tavakoli Y, Hoveidaei AH, Zareshahi N, Ghaseminejad-Raeini A.
    Bone; 2024 Nov 21; 188():117219. PubMed ID: 39089608
    [Abstract] [Full Text] [Related]

  • 20. Hypophosphatasia.
    Fenn JS, Lorde N, Ward JM, Borovickova I.
    J Clin Pathol; 2021 Oct 21; 74(10):635-640. PubMed ID: 33931563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.